Eurofins Scient (OTCMKTS:ERFSF) Stock Price Up 5.1% – Still a Buy?

Shares of Eurofins Scient (OTCMKTS:ERFSFGet Free Report) shot up 5.1% on Tuesday . The stock traded as high as $80.45 and last traded at $80.45. 492 shares changed hands during trading, a decline of 92% from the average session volume of 6,203 shares. The stock had previously closed at $76.51.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ERFSF. BNP Paribas Exane raised Eurofins Scient to an “outperform” rating in a research report on Monday, January 5th. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Get Our Latest Analysis on Eurofins Scient

Eurofins Scient Trading Up 0.5%

The firm has a 50-day moving average of $77.19 and a 200 day moving average of $74.55.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Featured Articles

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.